Eureka is a biotech company focused on T cell research and development. The company is engaged in R&D work aimed at advancing T cell science. Recently, Eureka secured a $60M financing round earmarked for its T cell R&D efforts. The article does not disclose investors, valuation, or the financing instrument. No operating metrics, founding year, or location are provided in the article.

Total raised

$60M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2018